AI Science Tracker
EN

A weakly supervised deep learning framework for automated PD-L1 expression analysis in lung cancer.

Affiliation not stated in the reviewed material · 31 Mar 2025 · medicine

Discovery

A weakly supervised deep learning framework for automated PD-L1 expression analysis in lung cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: Weakly supervised multiple-instance learning estimated lung-cancer PD-L1 scores with pathologist agreement in internal and external patient cohorts. The bibliographic records retrieved do not state an author affiliation.

Technology: ResNet18 plus attention and multiple-instance learning use slide-level pathologist labels; patient-level split produced internal and external evaluation.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ResNet18 plus attention and multiple-instance learning use slide-level pathologist labels; patient-level split produced internal and external evaluation.
Test and result
Pathologist-referenced TPS validation reports ICC 0.960 and external accuracy 81.7%; diagnostic assistance only, with prospective utility untested.
Limitation / still unknown
Weakly supervised multiple-instance learning estimated lung-cancer PD-L1 scores with pathologist agreement in internal and external patient cohorts. Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1540087/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.